scholarly journals Improving preprocedure antithrombotic management: Implementation and sustainment of a best practice alert and pharmacist referral process

2021 ◽  
Vol 5 (5) ◽  
Author(s):  
Henry Han ◽  
Grace Chung ◽  
Emily Sippola ◽  
Wilson Chen ◽  
Spencer Morgan ◽  
...  
Keyword(s):  
Best Practice ◽  
Referral Process ◽  
Best Practice Alert ◽  
Antithrombotic Management

Implementation of Best Practice Alert in an Electronic Medical Record to Limit Lower-Value Inpatient Echocardiograms

2018 ◽  
Vol 122 (9) ◽  
pp. 1574-1577 ◽  
Author(s):  
Adam Fleddermann ◽  
Steve Jones ◽  
Sarah James ◽  
Kevin F. Kennedy ◽  
Michael L. Main ◽  
...  
Keyword(s):  
Medical Record ◽  
Electronic Medical Record ◽  
Best Practice ◽  
Best Practice Alert

Association of a Best-Practice Alert and Prenatal Administration With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination Rates

2015 ◽  
Vol 126 (2) ◽  
pp. 333-337 ◽  
Author(s):  
Jamie L. Morgan ◽  
Sangameshwar R. Baggari ◽  
Wendy Chung ◽  
Julia Ritch ◽  
Donald D. McIntire ◽  
...  
Keyword(s):  
Tetanus Toxoid ◽  
Best Practice ◽  
Diphtheria Toxoid ◽  
Vaccination Rates ◽  
Best Practice Alert

scholarly journals Partners eCare Research Core for Clinical Research: Pilot to Build and Test Silent Best Practice Alert Notifications for Recruiting Inpatient Study Participants

Iproceedings ◽  
2017 ◽  
Vol 3 (1) ◽  
pp. e16
Author(s):  
Emily Caplan ◽  
Nina Schussler ◽  
Harriett Gabbidon ◽  
Lauren Cortese ◽  
Erick Maclean ◽  
...  
Keyword(s):  
Clinical Research ◽  
Best Practice ◽  
Best Practice Alert ◽  
Study Participants

scholarly journals 2344. Evaluation of a Best Practice Alert (BPA) to Reduce Inappropriate Testing for Clostridium difficile Infection (CDI) Within a Multi-Hospital System

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S805-S806
Author(s):  
Ryan K Dare ◽  
Claire E Bewley ◽  
Amanda J Novack ◽  
Jared M Heiles ◽  
Larissa K Chin
Keyword(s):  
Decision Support ◽  
Best Practice ◽  
Decision Support Tool ◽  
Medication Administration ◽  
Nucleic Acid Amplification ◽  
Or Education ◽  
Hospital System ◽  
Support Tool ◽  
Best Practice Alert ◽  
Hospital Acquired

Abstract Background Hospital-acquired CDI contribute to significant morbidity, mortality, and cost burden in hospitalized patients. Clinical practice guidelines recommend strict testing criteria when employing nucleic acid amplification testing alone as to not test asymptomatic carriers. A BPA within the electronic medical record (EMR) may assist with this screening. Methods At our 9-hospital system, we created a BPA to help identify patients who may not meet criteria for CDI testing. Initial BPA (January 2018) asked if patient had 3 or more stools (yes/no) and if laxatives were administered in the last 48 hours (yes/no). An expanded BPA was updated to pull medication administration records for use of laxatives in the prior 48 hours (August 2018) and notified providers of recent C. difficile testing in the past 7 days (January 2019). C. difficile orders from March 2017 (historical), March 2018 (intervention 1), and March 2019 (intervention 2) were evaluated to assess impact of these interventions. Results C. difficile testing during 30,621 (historical), 31,299 (intervention 1), and 31,960 (intervention 2) patient-days were evaluated. Rates of C. difficile orders and infections are reported in the table. Ratio of positive C. difficile specimens to tested specimens were similar between the historical arm (51 of 402; 12.7%) and both intervention 1 (42 of 271; 15.5%) and intervention 2 (45 of 316; 14.2%) arms (P = 0.3 and P = 0.5, respectively). Intervention 1 and intervention 2 arms were similar in all metrics. Statistical analysis was performed using Stata, v.14.2. Conclusion Implementation of a decision support tool to assist with C. difficile testing significantly decreased order rates in both the initial and expanded BPA intervention arms. Compared with historical rates, incidence of CDI decreased in both intervention arms though these were not statistically significant. Similarly, ratio of positive specimens to specimens tested increased in both intervention arms, though not significant, indicating a trend toward improved patient selection. To improve appropriate CDI testing, further oversight and/or education is needed to accompany implementation of an EMR decision support tool, such as BPAs. Disclosures All authors: No reported disclosures.

Sign in / Sign up

Export Citation Format

Share Document